---
title: "Evolocumab - Hypercholesterolemia"
sidebar: mydoc_sidebar
permalink: db09303-mesh-d006937-1.html
toc: false 
---


Path ID: `DB09303_MESH_D006937_1`
{% include image.html url="images/db09303-mesh-d006937-1.png" file="db09303-mesh-d006937-1.png" alt="db09303-mesh-d006937-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C577155 | Evolocumab | Drug |
| UniProt:Q8NBP7 | Proprotein convertase subtilisin/kexin type 9 | Protein |
| UniProt:P01130 | Low-density lipoprotein receptor | Protein |
| MESH:D008077 | Lipoproteins, LDL | ChemicalSubstance |
| MESH:D006937 | Hypercholesterolemia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Evolocumab | DECREASES ACTIVITY OF | Proprotein Convertase Subtilisin/Kexin Type 9 |
| Proprotein Convertase Subtilisin/Kexin Type 9 | DECREASES ACTIVITY OF | Low-Density Lipoprotein Receptor |
| Low-Density Lipoprotein Receptor | DECREASES ABUNDANCE OF | Lipoproteins, Ldl |
| Lipoproteins, Ldl | POSITIVELY CORRELATED WITH | Hypercholesterolemia |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB09303#mechanism-of-action](https://go.drugbank.com/drugs/DB09303#mechanism-of-action){:target="_blank"}